By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics (PTCT) Release: New Analyses of Translarna (Ataluren) Data From ACT DMD Presented At The 12th Annual European Pediatric Neurology Society Congress 6/22/2017 7:32:41 AM
PTC Therapeutics (PTCT) Announces FDA Advisory Committee Meeting For Ataluren For The Treatment Of Nonsense Mutation Dystrophinopathy 6/6/2017 10:47:14 AM
PTC Therapeutics (PTCT) Announces Executive Promotions 6/5/2017 11:22:32 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/5/2017 9:55:31 AM
PTC Therapeutics (PTCT) Release: New Analysis Of ACT DMD Placebo Data On Corticosteroids Presented At International Society For Pharmacoeconomics And Outcomes Research 22nd Annual International Meeting 5/24/2017 6:28:26 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/22/2017 6:54:47 AM
PTC Therapeutics (PTCT)'s New $35,000 Price Tag For MD Drug Draws Criticism And Doubt 5/9/2017 6:33:06 AM
PTC Therapeutics (PTCT) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/8/2017 10:15:57 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/27/2017 7:46:00 AM
PTC Therapeutics (PTCT) To Host Conference Call To Discuss First Quarter Financial Results 4/25/2017 9:42:07 AM
12345678910...
//-->